General paperInvolvement of protein kinase C and of protein phosphatases 1 and/or 2A in p47 phox phosphorylation in formylmet-leu-phe stimulated neutrophils: Studies with selective inhibitors RO 31-8220 and calyculin A
-
Add time:08/30/2019 Source:sciencedirect.com
Previously employed non-selective protein kinase inhibitors yielded inconclusive results regarding involvement of protein kinase C (PKC) in phosphorylation of 47 kDa protein (p47 phox) in intact neutrophils stimulated with physiologic agonists of superoxide generation. In the present study, phosphorylation of p47 phox in formylMet-Leu-Phe (fMLP) stimulated neutrophils was potently inhibited in the presence of 0.3 μM RO 31-8220, a selective inhibitor of PKC. These results provide experimental evidence in support of the currently considered essential involvement of PKC in p47 phox phosphorylation in response to physiologic stimulation of neutrophil surface receptors. The fMLP-induced phosphorylation of p47 phox was enhanced and prolonged by calyculin A, a specific inhibitor of protein phosphatases of types 1 and 2A, and such enhanced phosphorylation was also effectively inhibited by RO 31-8220. Our results suggest that the extent and duration of p47 phox phosphorylation in intact fMLP-stimulated neutrophils is probably controlled by a balance between the activities of PKC, on the one hand, and of protein phosphatase(s) of type(s) 1 and/or 2A, on the other. Effects of RO 31-8220 and of calyculin A on the fMLP-induced p47 phox phosphorylation were paralleled by similar effects on superoxide release. Calyculin A and RO 31-8220 were also used to study signal transduction by a post-receptor agonist of superoxide generation, a calcium ionophore A23187. The results of the latter study indicated that PKC was activated in A23187-stimulated neutrophils and was essentially involved in superoxide generation and p47 phox phosphorylation. Further, these results suggested that protein phosphatase(s) of type(s) 1 and/or 2A were also activated in A23187-signalling pathway, and limited the extent of superoxide release and p47 phox phosphorylation.
We also recommend Trading Suppliers and Manufacturers of RO-31-8220 (cas 138489-18-6). Pls Click Website Link as below: cas 138489-18-6 suppliers
Prev:Regular ArticleAtypical Isoforms of PKC and Insulin Secretion from Pancreatic β-Cells: Evidence Using Gö 6976 and Ro 31-8220 as PKC Inhibitors
Next:Original ContributionPalmitic Acid Anilide-Induced Respiratory Burst In Human Polymorphonuclear Leukocytes is Inhibited by a Protein Kinase C Inhibitor, Ro 31-8220) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Inhibition of voltage-dependent sodium channels by Ro 31-8220, a ‘specific’ protein kinase C inhibitor109/01/2019
- Original ContributionPalmitic Acid Anilide-Induced Respiratory Burst In Human Polymorphonuclear Leukocytes is Inhibited by a Protein Kinase C Inhibitor, Ro 31-822008/31/2019
- Regular ArticleAtypical Isoforms of PKC and Insulin Secretion from Pancreatic β-Cells: Evidence Using Gö 6976 and Ro 31-8220 as PKC Inhibitors08/29/2019
- Research paperInhibition by Ro 31-8220 of acid secretory activity induced by carbachol indicates a stimulatory role for protein kinase C in the action of muscarinic agonists on isolated rat parietal cells08/28/2019
- Regular ArticleThe PKC-Inhibitor RO 31-8220 Selectively Suppresses PMA- and Diacylglycerol-Induced Fluid Pinocytosis and Actin Polymerization in PMNS08/27/2019
- Dissociation of tyrosine phosphorylation and activation of phosphoinositide phospholipase C induced by the protein kinase C inhibitor RO-31-8220 (cas 138489-18-6) in Swiss 3T3 cells treated with platelet-derived growth factor08/26/2019
- RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages08/25/2019
- Ro 31-822008/24/2019
- Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster08/23/2019


